ArticlePharmaceuticals (Basel, Switzerland)2025

Adverse Drug Reactions to SGLT2i Reported by Type 2 Diabetes New Users: An Active Surveillance Study.

Camelia Bucșa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.